{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:53Z","timestamp":1707524633681},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,17]]},"DOI":"10.7759\/cureus.25090","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:06:36Z","timestamp":1652839596000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Hydronephrosis Secondary to Methadone-Induced Constipation"],"prefix":"10.7759","author":[{"given":"Sameer","family":"Kandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Chinta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P","family":"Urena Neme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Victoria Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"Rodriguez Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"NIDA. 2021, April 13. How do medications to treat opioid use disorder work?. (2022). Accessed. April 30, 2022: https:\/\/nida.nih.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/how-do-medications-to-treat-...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-125330008-6","article-title":"Pathophysiology, diagnosis, and management of opioid-induced constipation","volume":"3","author":"Farmer AD","year":"2018","unstructured":"Farmer AD, Holt CB, Downes TJ, Ruggeri E, Del Vecchio S, De Giorgio R. Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol Hepatol. 2018, 3:203-12. 10.1016\/S2468-125330008-6","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2019.32.2.69","article-title":"Opioid-induced constipation: a narrative review of therapeutic options in clinical management","volume":"32","author":"Lang-Illievich K","year":"2019","unstructured":"Lang-Illievich K, Bornemann-Cimenti H. Opioid-induced constipation: a narrative review of therapeutic options in clinical management. Korean J Pain. 2019, 32:69-78. 10.3344\/kjp.2019.32.2.69","journal-title":"Korean J Pain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174294","article-title":"Opioid addiction, genetic susceptibility, and medical treatments: a review","volume":"20","author":"Wang SC","year":"2019","unstructured":"Wang SC, Chen YC, Lee CH, Cheng CM. Opioid addiction, genetic susceptibility, and medical treatments: a review. Int J Mol Sci. 2019, 20:4294. 10.3390\/ijms20174294","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4751-4","article-title":"Opioid use disorder and treatment: challenges and opportunities","author":"Hoffman KA","year":"2019","unstructured":"Hoffman KA, Ponce Terashima J, McCarty D. Opioid use disorder and treatment: challenges and opportunities. StatPearls Publishing, Treasure Island, FL; 2019. 10.1186\/s12913-019-4751-4"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000789","article-title":"Discontinuing methadone and buprenorphine: a review and clinical challenges","volume":"15","author":"Zweben JE","year":"2021","unstructured":"Zweben JE, Sorensen JL, Shingle M, Blazes CK. Discontinuing methadone and buprenorphine: a review and clinical challenges. J Addict Med. 2021, 15:454-60. 10.1097\/ADM.0000000000000789","journal-title":"J Addict Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa186","article-title":"Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer","volume":"51","author":"Imai H","year":"2021","unstructured":"Imai H, Fumita S, Harada T, et al.. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer. Jpn J Clin Oncol. 2021, 51:444-50. 10.1093\/jjco\/hyaa186","journal-title":"Jpn J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1054423","article-title":"Opioid-induced constipation","volume":"50","author":"Gyawali B","year":"2015","unstructured":"Gyawali B, Hayashi N, Tsukuura H, Honda K, Shimokata T, Ando Y. Opioid-induced constipation. Scand J Gastroenterol. 2015, 50:1331-8. 10.3109\/00365521.2015.1054423","journal-title":"Scand J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.22.3.236","article-title":"The burden of opioid-induced constipation: discordance between patient and health care provider reports","volume":"22","author":"LoCasale RJ","year":"2016","unstructured":"LoCasale RJ, Datto C, Wilson H, Yeomans K, Coyne KS. The burden of opioid-induced constipation: discordance between patient and health care provider reports. J Manag Care Spec Pharm. 2016, 22:236-45. 10.18553\/jmcp.2016.22.3.236","journal-title":"J Manag Care Spec Pharm"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement [PREPRINT}","volume":"7","author":"Farmer AD","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, Tack J. Pathophysiology and management of opioid-induced constipation: European expert consensus statement [PREPRINT}. United European Gastroenterol J. 2019, 7:","journal-title":"United European Gastroenterol J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1232391","article-title":"High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments","volume":"17","author":"Lugoboni F","year":"2016","unstructured":"Lugoboni F, Mirijello A, Zamboni L, et al.. High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments. Expert Opin Pharmacother. 2016, 17:2135-41. 10.1080\/14656566.2016.1232391","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.09.024","article-title":"Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment","volume":"181","author":"Haber PS","year":"2017","unstructured":"Haber PS, Elsayed M, Espinoza D, Lintzeris N, Veillard AS, Hallinan R. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment. Drug Alcohol Depend. 2017, 181:132-9. 10.1016\/j.drugalcdep.2017.09.024","journal-title":"Drug Alcohol Depend"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i32.4350","article-title":"Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study","volume":"18","author":"Verma S","year":"2012","unstructured":"Verma S, Fogel J, Beyda DJ, Bernstein B, Notar-Francesco V, Mohanty SR. Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study. World J Gastroenterol. 2012, 18:4350-6. 10.3748\/wjg.v18.i32.4350","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8205","article-title":"Spontaneous recurrent pneumoperitoneum due to opioid-induced constipation: a case report","volume":"12","author":"Kaushal V","year":"2020","unstructured":"Kaushal V, Amoozgar B, Garala P, Bayanzay K, Sen S. Spontaneous recurrent pneumoperitoneum due to opioid-induced constipation: a case report. Cureus. 2020, 12:e8205. 10.7759\/cureus.8205","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4235\/agmr.20.0052","article-title":"Acute hydronephrosis owing to a giant fecaloma in an older patient","volume":"24","author":"Joo N","year":"2020","unstructured":"Joo N, Lee HS. Acute hydronephrosis owing to a giant fecaloma in an older patient. Ann Geriatr Med Res. 2020, 24:223-6. 10.4235\/agmr.20.0052","journal-title":"Ann Geriatr Med Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2021.7.53295","article-title":"Fatal abdominal compartment syndrome due to constipation: a case report","volume":"6","author":"Kongkatong MM","year":"2022","unstructured":"Kongkatong MM, Patel MM, Thom C, Moak J. Fatal abdominal compartment syndrome due to constipation: a case report. Clin Pract Cases Emerg Med. 2022, 6:8-12. 10.5811\/cpcem.2021.7.53295","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315627801","article-title":"Opioid-induced constipation: advances and clinical guidance","volume":"7","author":"Nelson AD","year":"2016","unstructured":"Nelson AD, Camilleri M. Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis. 2016, 7:121-34. 10.1177\/2040622315627801","journal-title":"Ther Adv Chronic Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.3.367","article-title":"Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial","volume":"283","author":"Yuan CS","year":"2000","unstructured":"Yuan CS, Foss JF, O'Connor M, Osinski J, Karrison T, Moss J, Roizen MF. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA. 2000, 283:367-72. 10.1001\/jama.283.3.367","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu M","year":"2002","unstructured":"Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage. 2002, 23:48-53. 10.1016\/S0885-3924(01)00369-4","journal-title":"J Pain Symptom Manage"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S99412","article-title":"Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem","volume":"11","author":"Yoon SC","year":"2017","unstructured":"Yoon SC, Bruner HC. Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem. Patient Prefer Adherence. 2017, 11:1265-71. 10.2147\/PPA.S99412","journal-title":"Patient Prefer Adherence"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97214-acute-hydronephrosis-secondary-to-methadone-induced-constipation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:54Z","timestamp":1707507594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97214-acute-hydronephrosis-secondary-to-methadone-induced-constipation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.25090","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,17]]}}}